Axcella Granted Patent for Long COVID Fatigue Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Axcella Granted Patent for Long COVID Fatigue Treatment

Axcella Therapeutics (AXLA) ramps 200% on new U.S. patent to treat long COVID fatigue

August 29, 2023 8:42 AM EDT

Axcella Therapeutics (NASDAQ: AXLA) surges 220% in pre-open trade after it was granted a U.S. patent to treat long COVID fatigue.

the U.S. Patent and Trademark Office (USPTO) has granted U.S. Patent No. 11,737,999 with claims covering methods of use of... More